Literature DB >> 6095403

Cerebrospinal fluid alterations in herpes simplex virus encephalitis.

M Koskiniemi, A Vaheri, E Taskinen.   

Abstract

Cellular and humoral alterations in the cerebrospinal fluid (CSF) of patients with herpes simplex virus (HSV) encephalitis are summarized. At the onset of signs of HSV encephalitis. CSF parameters may appear normal. Lymphoid pleocytosis is usual, and in some cases polymorphonuclear cells may dominate initially. The lymphoid reaction in CSF is prominent for months or even years after infection. Damage to the blood-brain barrier is variable. Total protein level and concentrations of IgG, IgM, and IgA increase in the early phase of the disease. The IgG content usually remains abnormal. Levels of HSV-specific IgG in the CSF increase in correspondence with total IgG content and remain high. A fairly consistent finding is the increased local IgG production in the central nervous system during HSV encephalitis. The ratio of the concentration of HSV antibody in serum to that in CSF is abnormal, usually from the second week of illness. In many cases a fourfold or greater increase in CSF antibody level is observed. The use of enzyme or radioimmunoassay in antibody determinations does not essentially hasten the diagnosis, and isolation of HSV or demonstration of its antigen in brain-biopsy specimens is the only way to achieve a conclusive diagnosis. The persistence of the CSF alterations suggests that HSV encephalitis is a chronic disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095403     DOI: 10.1093/clinids/6.5.608

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  17 in total

Review 1.  Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis.

Authors:  A C Cremieux; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

2.  Spread of herpes simplex virus to the cerebrospinal fluid and the meninges in experimental mouse encephalitis.

Authors:  R H Boerman; A C Peters; B R Bloem; A K Raap; M van der Ploeg
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Vetting requests for molecular diagnostics for CNS infections based on cerebrospinal fluid measurements undermines the quality of patient care.

Authors:  Zahir Osman Eltahir Babiker; Kenneth Mutton
Journal:  Clin Med (Lond)       Date:  2012-04       Impact factor: 2.659

4.  Artifacts in dilution pharmacokinetic models caused by adherent bacteria.

Authors:  R Haag; P Lexa; I Werkhäuser
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

5.  Herpes simplex virus encephalitis in children.

Authors:  E M Brett
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-29

6.  Regulation of the alginate biosynthesis gene algC in Pseudomonas aeruginosa during biofilm development in continuous culture.

Authors:  D G Davies; G G Geesey
Journal:  Appl Environ Microbiol       Date:  1995-03       Impact factor: 4.792

7.  Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease.

Authors:  F O Akenami; M Koskiniemi; M Färkkilä; A Vaheri
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

8.  Acute childhood encephalitis and meningoencephalitis: Diagnosis and management.

Authors:  E L Ford-Jones; D Macgregor; S Richardson; F Jamieson; S Blaser; H Artsob
Journal:  Paediatr Child Health       Date:  1998-01       Impact factor: 2.253

9.  Cerebrospinal fluid activity of tissue plasminogen activator in patients with neurological diseases.

Authors:  F O Akenami; V Sirén; M Koskiniemi; M A Siimes; H Teräväinen; A Vaheri
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

Review 10.  Viral Hypothesis and Antiviral Treatment in Alzheimer's Disease.

Authors:  D P Devanand
Journal:  Curr Neurol Neurosci Rep       Date:  2018-07-14       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.